Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I): Phase I xenobiotic metabolism in human skin and in vitro skin models

[1]  R. de Kanter,et al.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction , 2006, Expert opinion on drug metabolism & toxicology.

[2]  X. Jianming,et al.  N-Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[3]  J. Dupret,et al.  Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factors. , 2004, Current pharmaceutical design.

[4]  J. Southee,et al.  New epidermal model for dermal irritancy testing. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[5]  W B Jakoby,et al.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.

[6]  Y. Liu,et al.  UV irradiation induces Snail expression by AP-1 dependent mechanism in human skin keratinocytes. , 2010, Journal of dermatological science.

[7]  J. Schellens,et al.  Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. , 2006, Toxicology and applied pharmacology.

[8]  R. Minchin,et al.  Arylamine N-acetyltransferase I. , 2007, The international journal of biochemistry & cell biology.

[9]  M. Denison,et al.  Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. , 2003, Annual review of pharmacology and toxicology.

[10]  Marilyn J Aardema,et al.  Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). , 2006, Mutation research.

[11]  R. E. Stevenson,et al.  Establishment of a strain of human skin cells on chemically defined medium NCTC 109. , 1961, American journal of hygiene.

[12]  H. Mukhtar,et al.  Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. , 1984, The Journal of investigative dermatology.

[13]  W. Weber,et al.  New spectrophotometric and radiochemical assays for acetyl-CoA: arylamine N-acetyltransferase applicable to a variety of arylamines. , 1985, Analytical biochemistry.

[14]  D. Miranda,et al.  Copper modifies liver microsomal UDP-glucuronyltransferase activity through different and opposite mechanisms. , 2007, Chemico-biological interactions.

[15]  R. Tukey,et al.  Human UDP-glucuronosyltransferases: metabolism, expression, and disease. , 2000, Annual review of pharmacology and toxicology.

[16]  R Roguet,et al.  The use of in vitro reconstituted human skin in dermotoxicity testing. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[18]  N. Hewitt,et al.  Skin metabolism of aminophenols: human keratinocytes as a suitable in vitro model to qualitatively predict the dermal transformation of 4-amino-2-hydroxytoluene in vivo. , 2009, Toxicology and applied pharmacology.

[19]  P. Schröder,et al.  Direct Effect of CD on Glutathione S-Transferase and Glutathione Reductase from Calystegia Sepium , 2007, International journal of phytoremediation.

[20]  R. Moeller,et al.  Impact of para-phenylenediamine on cyclooxygenases expression and prostaglandin formation in human immortalized keratinocytes (HaCaT). , 2008, Toxicology.

[21]  Y. Fujii‐Kuriyama,et al.  Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Takashi Sato,et al.  Induction of inflammatory reactions by lipopolysaccharide in hamster sebaceous glands and pilosebaceous units in vivo and in vitro , 2010, Experimental dermatology.

[23]  M. Pirmohamed,et al.  Metabolic activation in drug allergies. , 2001, Toxicology.

[24]  I. Merkatz,et al.  Induction of Benzo[α]pyrene Hydroxylase in Human Skin , 1972, Science.

[25]  H. Mukhtar,et al.  Glutathione S-transferases in human and rodent skin: multiple forms and species-specific expression. , 1991, The Journal of investigative dermatology.

[26]  D. G. McCarver,et al.  The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. , 2002, The Journal of pharmacology and experimental therapeutics.

[27]  V. Adhami,et al.  Cancer Chemoprevention by Pomegranate: Laboratory and Clinical Evidence , 2009, Nutrition and cancer.

[28]  T. Nishikawa,et al.  High capacity of human skin for N-acetylation of arylamines. , 1990, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[29]  S. Frankenberg,et al.  Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes. , 2001, The Journal of investigative dermatology.

[30]  F. Sörgel,et al.  Inhibition of uridinediphosphate glucuronyltransferase caused by furosemide , 1980, Experientia.

[31]  P. Jansen,et al.  Impaired hepatocanalicular organic anion transport in endotoxemic rats. , 1995, The American journal of physiology.

[32]  E. Fabian,et al.  Characterization of enzyme activities of Cytochrome P450 enzymes, Flavin-dependent monooxygenases, N-acetyltransferases and UDP-glucuronyltransferases in human reconstructed epidermis and full-thickness skin models. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[33]  J Kao,et al.  Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. , 1985, Toxicology and applied pharmacology.

[34]  H. Merk,et al.  N-Acetylation of paraphenylenediamine in human skin and keratinocytes. , 2000, The Journal of pharmacology and experimental therapeutics.

[35]  Postnatal development of hepatic oxidative, hydrolytic and conjugative drug-metabolizing enzymes in female horses. , 2004, Life sciences.

[36]  R. Edwards,et al.  Expression of P450 enzymes in rat whole skin and cultured epidermal keratinocytes. , 2002, Biochemical and biophysical research communications.

[37]  J. Leoni,et al.  Time-course evaluation and treatment of skin inflammatory immune response after ultraviolet B irradiation. , 2008, Cytokine.

[38]  Jun Yao,et al.  Cyclooxygenase-2 expression during immortalization and breast cancer progression. , 2008, Cancer research.

[39]  J. Dairou,et al.  Peroxynitrite Irreversibly Inactivates the Human Xenobioticmetabolizing Enzyme Arylamine N-Acetyltransferase 1 (NAT1) in Human Breast Cancer Cells , 2004, Journal of Biological Chemistry.

[40]  D. Bickers,et al.  Reconstituted 3-dimensional human skin as a novel in vitro model for studies of carcinogenesis. , 1999, Biochemical and biophysical research communications.

[41]  A. Galetin,et al.  Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[42]  J. Dupret,et al.  Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases. , 2005, Current medicinal chemistry.

[43]  S. Hansen,et al.  Evaluation of cytochrome P450 activity in vitro, using dermal and hepatic microsomes from four species and two keratinocyte cell lines in culture , 2007, Archives of Dermatological Research.

[44]  J. Hennen,et al.  Evaluation of cytochrome P450 1 (CYP1) and N-acetyltransferase 1 (NAT1) activities in HaCaT cells: implications for the development of in vitro techniques for predictive testing of contact sensitizers. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[45]  P. Lipsky,et al.  Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  R L Binder,et al.  Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[47]  H. Merk,et al.  Skin: major target organ of allergic reactions to small molecular weight compounds. , 2007, Toxicology and applied pharmacology.

[48]  C. Higgins,et al.  Modelling the hair follicle dermal papilla using spheroid cell cultures , 2010, Experimental dermatology.

[49]  T. Sieber,et al.  Skin sensitization to p-phenylenediamine: the diverging roles of oxidation and N-acetylation for dendritic cell activation and the immune response. , 2009, The Journal of investigative dermatology.

[50]  S. Seité,et al.  A broad‐spectrum sunscreen prevents UVA radiation‐induced gene expression in reconstructed skin in vitro and in human skin in vivo , 2011, Experimental dermatology.

[51]  R L Bartel,et al.  Characterization, barrier function, and drug metabolism of an in vitro skin model. , 1993, The Journal of investigative dermatology.

[52]  L. Klotz,et al.  Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation , 2007, Proceedings of the National Academy of Sciences.

[53]  S. D. Turner,et al.  Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[54]  A. Conney,et al.  Inducibility of benzo [α] pyrene hydroxylase in human skin by polycyclic hydrocarbons , 1973, Clinical pharmacology and therapeutics.

[55]  J. Goldstein,et al.  Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: I. Expression and Role of Cytochromes P450 , 2006, Journal of Pharmacology and Experimental Therapeutics.

[56]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[57]  J. Hayes,et al.  Glutathione S-Transferase Polymorphisms and Their Biological Consequences , 2000, Pharmacology.

[58]  A. Rane,et al.  Glutathione S-transferase in humans: development and tissue distribution , 2004, Archives of Toxicology.

[59]  H. Mukhtar,et al.  Aryl hydrocarbon receptor is an ozone sensor in human skin. , 2009, The Journal of investigative dermatology.

[60]  K. Wittern,et al.  Comparison of Activities Dependent on Glutathione S-Transferase and Cytochrome P-450 IA1 in Cultured Keratinocytes and Reconstructed Epidermal Models , 2002, Skin Pharmacology and Physiology.

[61]  A. Rannug,et al.  The aryl hydrocarbon receptor and light , 2006, Biological chemistry.

[62]  J. Lotem,et al.  NQO1 stabilizes p53 through a distinct pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[63]  O. Pelkonen,et al.  Cytochrome P450 (CYP) inhibition screening: comparison of three tests. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[64]  A. Li,et al.  Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[65]  H. Maibach,et al.  Metabolism of 3-indolylacetic acid during percutaneous absorption in human skin. , 1993, Journal of pharmaceutical sciences.

[66]  H. Merk,et al.  Expression and Induction of Cytochrome P450 Isoenzymes in Human Skin Equivalents , 2010, Skin Pharmacology and Physiology.

[67]  H. Swanson.  Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. , 2004, Chemico-biological interactions.

[68]  P. D. Josephy,et al.  Human acetyl CoA:arylamine N-acetyltransferase variants generated by random mutagenesis. , 2004, Molecular pharmacology.

[69]  D. Howes,et al.  Percutaneous penetration and dermal metabolism of triclosan (2,4, 4'-trichloro-2'-hydroxydiphenyl ether). , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[70]  C. Vogel.  Prostaglandin H synthases and their importance in chemical toxicity. , 2000, Current drug metabolism.

[71]  H. Mukhtar,et al.  Cytochrome p450: a target for drug development for skin diseases. , 2004, The Journal of investigative dermatology.

[72]  L. Wattenberg,et al.  HISTOCHEMICAL DEMONSTRATION OF REDUCED PYRIDINE NUCLEOTIDE DEPENDENT POLYCYCLIC HYDROCARBON METABOLIZING SYSTEMS , 1962 .

[73]  D. Moody,et al.  Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[74]  C. K. Svensson,et al.  Biotransformation of Drugs in Human Skin , 2009, Drug Metabolism and Disposition.

[75]  C. Wolf,et al.  Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. , 1990, Carcinogenesis.

[76]  Robert Landsiedel,et al.  Drug-Metabolizing Enzymes in the Skin of Man, Rat, and Pig , 2007, Drug metabolism reviews.

[77]  A. D. Rodrigues,et al.  Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[78]  J. Angerer,et al.  Penetration of β-naphthylamine and o-toluidine through human skin in vitro , 2006, Archives of Toxicology.

[79]  H. Mukhtar,et al.  Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. , 2000, The Journal of investigative dermatology.

[80]  H. Merk,et al.  Cutaneous metabolic activation of carvoxime, a self-activating, skin-sensitizing prohapten. , 2009, Chemical research in toxicology.

[81]  B. Ring,et al.  The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[82]  T. Warner,et al.  Origins of Prostaglandin E2: Involvements of Cyclooxygenase (COX)-1 and COX-2 in Human and Rat Systems , 2002, Journal of Pharmacology and Experimental Therapeutics.

[83]  E. Golovinsky,et al.  Natural and synthetic inhibitors of UDP-glucuronosyltransferase. , 2001, Pharmacology & therapeutics.

[84]  Jean Krutmann,et al.  Role of HuR and p38MAPK in Ultraviolet B-induced Post-transcriptional Regulation of COX-2 Expression in the Human Keratinocyte Cell Line HaCaT* , 2009, The Journal of Biological Chemistry.

[85]  Jamshed Anwar,et al.  Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes. , 2006, Journal of the American Chemical Society.

[86]  N. Hewitt,et al.  Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro–in vivo correlations , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[87]  S. Penco,et al.  Induction by xenobiotics of phase I and phase II enzyme activities in the human keratinocyte cell line NCTC 2544. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[88]  G. Rimbach,et al.  Sulforaphane but not ascorbigen, indole‐3‐carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase‐2 and antioxidant enzymes in human keratinocytes in culture , 2010, Experimental dermatology.

[89]  Hongbing Wang,et al.  The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[90]  Min-Jian Xu,et al.  Expression and regulation of glutathione S-transferase P1-1 in cultured human epidermal cells. , 2002, Journal of dermatological science.

[91]  Sue Gibbs,et al.  Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. , 2007, Current drug metabolism.

[92]  A. Guillouzo,et al.  In Vitro expression of drug metabolizing enzyme activities in human adult keratinocytes under various culture conditions and their response to inducers. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[93]  R. Mayer,et al.  7-Alkoxyquinoline O-dealkylation by microsomes from human liver and placenta. , 1992, British journal of clinical pharmacology.

[94]  D. Grant,et al.  Human acetyltransferase polymorphisms. , 1997, Mutation research.

[95]  H. Mukhtar,et al.  Human hair follicle benzo[a]pyrene and benzo[a]pyrene 7,8-diol metabolism: effect of exposure to a coal tar-containing shampoo. , 1987, The Journal of investigative dermatology.

[96]  D. Eaton,et al.  Concise review of the glutathione S-transferases and their significance to toxicology. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[97]  M. Matsui,et al.  Green Tea Phenol Extracts Reduce UVB‐induced DNA Damage in Human Cells via Interleukin‐12 † , 2008, Photochemistry and photobiology.